Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Powers

Showing results (251-260 of 255) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 255 results.
Journal of Medicinal Chemistry|May 23, 2025
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer TherapyDillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu, et al.
Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
Journal of Medicinal Chemistry|June 5, 2026
Discovery of Casdatifan, Part II: A Potent and Orally Bioavailable Inhibitor of Hypoxia Inducible Factor-2αArtur K Mailyan, Guillaume Mata, Joel W Beatty, et al.
Journal of Medicinal Chemistry|October 21, 2021
Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)Guillaume Mata, Dillon H Miles, Samuel L Drew, et al.
Journal of Medicinal Chemistry|September 1, 2020
Discovery of Potent and Selective PI3Kγ InhibitorsSamuel L Drew, Rhiannon Thomas-Tran, Joel W Beatty, et al.
Pageof 26

Showing results (251-260 of 255) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 255 results.
Journal of Medicinal Chemistry|May 23, 2025
Discovery of AB801, a Potent and Selective Inhibitor of AXL Receptor Tyrosine Kinase for Use in Cancer TherapyDillon H Miles, Manjunath Lamani, Srinivas Reddy Paladugu, et al.
Journal of Medicinal Chemistry|April 20, 2013
Rational design and binding mode duality of MDM2-p53 inhibitorsFelix Gonzalez-Lopez de Turiso, Daqing Sun, Yosup Rew, et al.
Journal of Medicinal Chemistry|June 5, 2026
Discovery of Casdatifan, Part II: A Potent and Orally Bioavailable Inhibitor of Hypoxia Inducible Factor-2αArtur K Mailyan, Guillaume Mata, Joel W Beatty, et al.
Journal of Medicinal Chemistry|October 21, 2021
Design, Synthesis, and Structure-Activity Relationship Optimization of Pyrazolopyrimidine Amide Inhibitors of Phosphoinositide 3-Kinase γ (PI3Kγ)Guillaume Mata, Dillon H Miles, Samuel L Drew, et al.
Journal of Medicinal Chemistry|September 1, 2020
Discovery of Potent and Selective PI3Kγ InhibitorsSamuel L Drew, Rhiannon Thomas-Tran, Joel W Beatty, et al.
Pageof 26